These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24581034)
41. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Goldstein JN; Marrero M; Masrur S; Pervez M; Barrocas AM; Abdullah A; Oleinik A; Rosand J; Smith EE; Dzik WH; Schwamm LH Arch Neurol; 2010 Aug; 67(8):965-9. PubMed ID: 20697046 [TBL] [Abstract][Full Text] [Related]
42. Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke. Van Hooff RJ; Nieboer K; De Smedt A; Moens M; De Deyn PP; De Keyser J; Brouns R Clin Neurol Neurosurg; 2014 Oct; 125():189-93. PubMed ID: 25171393 [TBL] [Abstract][Full Text] [Related]
43. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Lansberg MG; Thijs VN; Bammer R; Kemp S; Wijman CA; Marks MP; Albers GW; Stroke; 2007 Aug; 38(8):2275-8. PubMed ID: 17569874 [TBL] [Abstract][Full Text] [Related]
44. Endovascular stroke therapy may be safe in patients with elevated international normalized ratio. Mundiyanapurath S; Tillmann A; Möhlenbruch MA; Bendszus M; Ringleb PA J Neurointerv Surg; 2017 Dec; 9(12):1187-1190. PubMed ID: 27856650 [TBL] [Abstract][Full Text] [Related]
45. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Strbian D; Engelter S; Michel P; Meretoja A; Sekoranja L; Ahlhelm FJ; Mustanoja S; Kuzmanovic I; Sairanen T; Forss N; Cordier M; Lyrer P; Kaste M; Tatlisumak T Ann Neurol; 2012 May; 71(5):634-41. PubMed ID: 22522478 [TBL] [Abstract][Full Text] [Related]
46. IV thrombolysis and statins. Engelter ST; Soinne L; Ringleb P; Sarikaya H; Bordet R; Berrouschot J; Odier C; Arnold M; Ford GA; Pezzini A; Zini A; Rantanen K; Rocco A; Bonati LH; Kellert L; Strbian D; Stoll A; Meier N; Michel P; Baumgartner RW; Leys D; Tatlisumak T; Lyrer PA Neurology; 2011 Aug; 77(9):888-95. PubMed ID: 21849650 [TBL] [Abstract][Full Text] [Related]
47. Intravenous Thrombolysis for Ischemic Stroke Patients on Dual Antiplatelets. Tsivgoulis G; Katsanos AH; Mavridis D; Gdovinova Z; Karliński M; Macleod MJ; Strbian D; Ahmed N Ann Neurol; 2018 Jul; 84(1):89-97. PubMed ID: 30048012 [TBL] [Abstract][Full Text] [Related]
48. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N; Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853 [TBL] [Abstract][Full Text] [Related]
49. Symptomatic post-thrombolytic intracerebral hemorrhage is not related to the cause of stroke. Curtze S; Sibolt G; Melkas S; Mustanoja S; Haapaniemi E; Putaala J; Sairanen T; Tiainen M; Tatlisumak T; Strbian D Eur J Neurol; 2016 Dec; 23(12):1700-1704. PubMed ID: 27591741 [TBL] [Abstract][Full Text] [Related]
50. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis. Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038 [TBL] [Abstract][Full Text] [Related]
51. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Singer OC; Humpich MC; Fiehler J; Albers GW; Lansberg MG; Kastrup A; Rovira A; Liebeskind DS; Gass A; Rosso C; Derex L; Kim JS; Neumann-Haefelin T; Ann Neurol; 2008 Jan; 63(1):52-60. PubMed ID: 17880020 [TBL] [Abstract][Full Text] [Related]
52. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Cocho D; Borrell M; Martí-Fàbregas J; Montaner J; Castellanos M; Bravo Y; Molina-Porcel L; Belvís R; Díaz-Manera JA; Martínez-Domeño A; Martínez-Lage M; Millán M; Fontcuberta J; Martí-Vilalta JL Stroke; 2006 Apr; 37(4):996-9. PubMed ID: 16497981 [TBL] [Abstract][Full Text] [Related]
55. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Saver JL Stroke; 2007 Aug; 38(8):2279-83. PubMed ID: 17641238 [TBL] [Abstract][Full Text] [Related]
56. Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke. Zou M; Churilov L; He A; Campbell B; Davis SM; Yan B J Clin Neurosci; 2013 Jul; 20(7):984-7. PubMed ID: 23664409 [TBL] [Abstract][Full Text] [Related]
57. Relationship between reperfusion and intracranial hemorrhage after thrombectomy. Desai SM; Tonetti DA; Morrison AA; Gross BA; Jankowitz BT; Jovin TG; Jadhav AP J Neurointerv Surg; 2020 May; 12(5):448-453. PubMed ID: 31649204 [TBL] [Abstract][Full Text] [Related]
58. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome. Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586 [TBL] [Abstract][Full Text] [Related]
59. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). Ahmed N; Dávalos A; Eriksson N; Ford GA; Glahn J; Hennerici M; Mikulik R; Kaste M; Lees KR; Lindsberg PJ; Toni D; Arch Neurol; 2010 Sep; 67(9):1123-30. PubMed ID: 20837858 [TBL] [Abstract][Full Text] [Related]
60. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A; Dzialowski I; Koch R; Gahn G J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]